Trial | NCT00653744  Report issue

Title

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
A 6-Week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects. (ARIES)

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    1700
The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in African American subjects with hypercholesterolemia.
Study Started
Mar 31
2002
Study Completion
Mar 31
2004
Last Update
Mar 16
2009
Estimate

Drug Rosuvastatin

  • Other names: Crestor

Drug Atorvastatin

  • Other names: Lipitor

1 Experimental

Rosuvastatin

2 Active Comparator

Atorvastatin

Criteria 

Inclusion Criteria:

Fasting low density lipoprotein level as defined by the protocol.
Self described African American race
Fasting triglyceride level as defined by the protocol.

Exclusion Criteria:

The use of lipid lowering drugs or dietary supplements after Visit 1.
Active arterial disease eg Unstable angina, or recent arterial surgery
Blood lipid levels above the limits defined in the protocol.
Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse.
No Results Posted